Long-term risks after splenectomy among 8,149 cancer-free American veterans: A cohort study with up to 27 years follow-up

Haematologica

Volumn 99, Issue 2, 2014, Pages 392-398

  Kristinsson, Sigurdur Y ^a   Gridley, Gloria ^b   Hoover, Robert N ^b   Check, David ^b   Landgren, Ola ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN ISCHEMIA; BUCCAL CANCER; COLON CANCER; CORONARY ARTERY DISEASE; DEATH; DEEP VEIN THROMBOSIS; ESOPHAGUS CANCER; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; INFECTION; LEUKEMIA; LIVER CANCER; LUNG CANCER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORTALITY; NEOPLASM; PANCREAS CANCER; PNEUMONIA; PROSTATE CANCER; SEPTICEMIA; SPLENECTOMY; STREPTOCOCCUS PNEUMONIA; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SPLENECTOMY; SURVIVAL RATE; UNITED STATES; VETERANS;

EID: 84896702531     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.092460     Document Type: Article

References (47)

1. Bowdler AJ. The Complete Spleen: Structure, Function and Clinical Significance: Humana Pr Inc, 2001.
2. Sheikha AK, Salih ZT, Kasnazan KH, Khoshnaw MK, Al-Maliki T, Al-Azraqi TA, et al. Prevention of overwhelming postsplenectomy infection in thalassemia patients by partial rather than total splenectomy. Can J Surg. 2007;50(5):382-6.
3. Crary SE, Buchanan GR. Vascular complications after splenectomy for hematologic disorders. Blood. 2009;114(14):2861-8.
4. Schulkind ML, Ellis EF, Smith RT. Effect of antibody upon clearance of I-125-labelled pneumococci by the spleen and liver. Pediatr Res. 1967;1(3):178-84.
5. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect. 2001;43(3):182-6.
6. Cullingford GL, Watkins DN, Watts AD, Mallon DF. Severe late postsplenectomy infection. Br J Surg. 1991;78(6):716-21.
7. Dickerman JD. Bacterial infection and the asplenic host: a review. J Trauma. 1976;16 (08):662-8.
8. Ejstrud P, Kristensen B, Hansen JB, Madsen KM, Schonheyder HC, Sorensen HT. Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand J Infect Dis. 2000;32(5):521-5.
9. Linet MS, Nyren O, Gridley G, Adami HO, Buckland JD, McLaughlin JK, et al. Causes of death among patients surviving at least one year following splenectomy. Am J Surg. 1996;172(4):320-3.
10. Robinette CD, Fraumeni JF Jr. Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet. 1977;2(8029):127-9.
11. Schwartz PE, Sterioff S, Mucha P, Melton LJ, Offord KP. Postsplenectomy sepsis and mortality in adults. JAMA. 1982;248(18): 2279-83.
12. Walker W. Splenectomy in childhood: a review in England and Wales, 1960-4. Br J Surg. 1976;63(1):36-43.
13. Eraklis AJ, Kevy SV, Diamond LK, Gross RE. Hazard of overwhelming infection after splenectomy in childhood. N Engl J Med. 1967;276(22):1225-9.
14. King H, Shumacker HB, Jr. Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg. 1952;136 (2):239-42.
15. Green JB, Shackford SR, Sise MJ, Fridlund P. Late septic complications in adults following splenectomy for trauma: a prospective analysis in 144 patients. J Trauma. 1986;26 (11):999-1004.
16. Alebouyeh M, Moussavi F. Occurrence of overwhelming gram-negative infections in splenectomised patients with thalassaemia major. Eur J Pediatr. 2003;162(9):637-8.
17. Altamura M, Caradonna L, Amati L, Pellegrino NM, Urgesi G, Miniello S. Splenectomy and sepsis: the role of the spleen in the immune-mediated bacterial clearance. Immunopharmacol Immunotoxicol. 2001;23(2):153-61.
18. Constantopoulos A, Najjar VA, Wish JB, Necheles TH, Stolbach LL. Defective phagocytosis due to tuftsin deficiency in splenectomized subjects. Am J Dis Child. 1973;125 (5):663-5.
19. Rowley DA. The formation of circulating antibody in the splenectomized human being following intravenous injection of heterologous erythrocytes. J Immunol. 1950;65(5):515-21.
20. Hirsh J, Dacie JV. Persistent post-splenectomy thrombocytosis and thromboembolism: a consequence of continuing anaemia. Br J Haematol. 1966;12(1):44-53.
21. Salter PP Jr, Sherlock EC. Splenectomy, thrombocytosis, and venous thrombosis. Am Surg. 1957;23(6):549-54.
22. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol. 2000;111 (2):467-73.
23. Pimpl W, Dapunt O, Kaindl H, Thalhamer J. Incidence of septic and thromboembolicrelated deaths after splenectomy in adults. Br J Surg. 1989;76(5):517-21.
24. Dawson AA, Bennett B, Jones PF, Munro A. Thrombotic risks of staging laparotomy with splenectomy in Hodgkin's disease. Br J Surg. 1981;68(12):842-5.
25. Hassn AM, Al-Fallouji MA, Ouf TI, Saad R. Portal vein thrombosis following splenectomy. Br J Surg. 2000;87(3):362-73.
26. Rossi P, Passariello R, Simonetti G. Portal thrombosis: high incidence following splenectomy for portal hypertension. Gastrointest Radiol. 1976;1(3):225-7.
27. Stamou KM, Toutouzas KG, Kekis PB, Nakos S, Gafou A, Manouras A, et al. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg. 2006;141(7):663-9.
28. Hull CC, Galloway P, Gordon N, Gerson SL, Hawkins N, Stellato TA. Splenectomy and the induction of murine colon cancer. Arch Surg. 1988;123(4):462-4.
29. Yamagishi H, Pellis NR, Kahan BD. Effect of splenectomy upon tumor growth: characterization of splenic tumor-enhancing cells in vivo. Surgery. 1980;87(6):655-61.
30. Soda K, Kawakami M, Takagi S, Kashii A, Miyata M. Splenectomy before tumor inoculation prolongs the survival time of cachectic mice. Cancer Immunol Immunother. 1995;41(4):203-9.
31. Mellemkjoer L, Olsen JH, Linet MS, Gridley G, McLaughlin JK. Cancer risk after splenectomy. Cancer. 1995;75(2):577-83.
32. Linet MS, Nyren O, Gridley G, Mellemkjaer L, McLaughlin JK, Olsen JH, et al. Risk of cancer following splenectomy. Int J Cancer. 1996;66(5):611-6.
33. Richardson C, Waldrop J. Veterans: 2000 Census 2000 Brief, Bureau UC Washington DC: Department of Commerce, 2003.
34. Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, Baris D, et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood. 2006;107(3):904-6.
35. Boyko EJ, Koepsell TD, Gaziano JM, Horner RD, Feussner JR. US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol. 2000;151 (3):307-14.
36. Page WF, Mahan CM, Kang HK. Vital status ascertainment through the files of the Department of Veterans Affairs and the Social Security Administration. Ann Epidemiol. 1996;6(2):102-9.
37. Breslow N, Langholz B. Nonparametric estimation of relative mortality functions. J Chronic Dis. 1987;40 (Suppl 2):89S-99S.
38. Karanika M, Vasilopoulou VA, Katsioulis AT, Papastergiou P, Theodoridou MN, Hadjichristodoulou CS. Diagnostic clinical and laboratory findings in response to predetermining bacterial pathogen: data from the Meningitis Registry. PLoS One. 2009;4(7): e6426.
39. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009;374(9700):1543-56.
40. Landgren O, Bjorkholm M, Konradsen HB, Soderqvist M, Nilsson B, Gustavsson A, et al. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma. J Intern Med. 2004;255(6):664-73.
41. Cherif H, Landgren O, Konradsen HB, Kalin M, Bjorkholm M. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine. 2006;24(1):75-81.
42. Davies JM, Barnes R, Milligan D. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med. 2002;2(5): 440-3.
43. Goldin LR, Landgren O. Autoimmunity and lymphomagenesis. Int J Cancer. 2009;124(7): 1497-502.
44. Delaitre B, Maignien B, Icard P. Laparoscopic splenectomy. Br J Surg. 1992;79(12):1334.
45. Park A, Marcaccio M, Sternbach M, Witzke D, Fitzgerald P. Laparoscopic vs open splenectomy. Arch Surg. 1999;134(11):1263-9.
46. Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF Jr. Acromegaly and gastrointestinal cancer. Cancer. 1991;68(8):1673-7.
47. Gridley G, Klippel JH, Hoover RN, Fraumeni JF Jr. Incidence of cancer among men with the Felty syndrome. Ann Intern Med. 1994;120(1):35-9.